Inpharma

Dexamethasone may solve the headache of migraine recurrence
pp. 1-1(1)

DTC advertising in disguise?
pp. 2-2(1)

T2DM treatment ADVANCE comes with caveats
pp. 3-4(2)

Veterans Affairs Diabetes Trial vindicates rosiglitazone?
pp. 4-4(1)

ACCORD study finding of increased mortality raises questions
pp. 5-5(1)

T2DM treatment targets scrutinised at ADA: nothing needs to change
pp. 6-7(2)

Economic worth of US DOD weapons for diarrhoea tested
pp. 8-8(1)

Deferasirox dominates deferoxamine for iron control
pp. 8-8(1)

To sleep, perchance to dream: eszopiclone knocks out insomnia
pp. 8-8(1)

Bird flu vaccine flying high
pp. 9-9(1)

Telaprevir also PROVEs useful in refractory hep C
pp. 9-9(1)

Conestat-α ready for next step
pp. 9-9(1)

R&D news from ATS
pp. 10-10(1)

A potential therapy for Alzheimer's disease has been identified from a study in a model mouse.
pp. 10-10(1)

Alogliptin alleviates type 2 diabetes burden
pp. 11-12(2)

E. coli vaccine patch promising for traveller's diarrhoea
pp. 12-12(1)

R&D news from EHA
pp. 13-13(1)

Biovest International has reported tantalising blinded results from a pivotal phase III study of its non-Hodgkin's lymphoma (NHL) vaccine
pp. 13-13(1)

Leaders in the field of stem cell research have released draft guidelines to ensure translation of research from the laboratory to the patient.
pp. 13-13(1)

GlaxoSmithKline's candidate paediatric pneumococcal vaccine GSK 1024850A [Synflorix] has the potential to offer increased protection
pp. 14-14(1)

Cook Medical's paclitaxel-eluting peripheral stent [Zilver PTX] has performed well
pp. 14-14(1)

GRNCM1 avoids direct attack by the human immune system in vitro,
pp. 14-14(1)

European enrolment initiated for clopidogrel/omeprazole trial.
pp. 14-14(1)

Ketoprofen phase III trial initiated.
pp. 14-14(1)

A novel nanoviricide anti-HIV drug candidate has outperformed an antiretroviral 'combo cocktail'
pp. 14-14(1)

Carbocisteine PEACE has a place in the puzzle of COPD
pp. 15-15(1)

Budesonide in surfactant improves outcome in premature infants
pp. 15-15(1)

Pramipexole kicks RLS limb pain
pp. 15-15(1)

Lenalidomide lends a helping hand for MM and NHL
pp. 16-16(1)

Albendazole demonstrated effectiveness in patients with idiopathic eosinophilia
pp. 16-16(1)

Just one antibacterial dose helps healing
pp. 16-16(1)

Mesalazine beneficial for long-term treatment of UC
pp. 16-16(1)

Thiazolidinedione treatment is not associated with an increased risk of major adverse cardiovascular events
pp. 17-17(1)

Glargine, NPH insulin eye-to-eye for retinopathy
pp. 17-17(1)

Antibacterial class does not affect outcome in mild CAP
pp. 17-17(1)

ARB benefit pushes beyond hypertension
pp. 17-17(1)

ADAGIO results music to the ears of Parkinson's patients
pp. 17-17(1)

Micronutrient supplementation is associated with improved outcomes in patients with pulmonary tuberculosis
pp. 18-18(1)

Exenatide monotherapy is effective for the treatment of patients with type 2 diabetes mellitus
pp. 18-18(1)

Clofibrate sped the resolution of hyperbilirubinaemia in neonates with G6PD deficiency-associated jaundice
pp. 18-18(1)

A short course of antibacterials is as effective as a longer course in patients with chronic bronchitis or chronic obstructive pulmonary disease
pp. 18-18(1)

Intensive combination therapy beneficial for early active RA
pp. 18-18(1)

Medical resource use can be reduced by administering doripenem rather than imipenem for ventilator-associated pneumonia
pp. 19-19(1)

Etoricoxib appears to be beneficial during off-phases of intermittent androgen deprivation therapy
pp. 19-19(1)

The addition of montelukast to inhaled corticosteroids improves control of mild-to-moderate asthma
pp. 19-19(1)

Reduced-duration bupropion may be as effective as standard-duration bupropion for smoking cessation
pp. 19-19(1)

Ethinylestradiol/chlormadinone appears to be an effective oral contraceptive in the long-term, and also provides additional benefits
pp. 19-19(1)

Postoperative analgesic requirements are reduced by the addition of ketamine
pp. 19-19(1)

Saving kidneys
pp. 20-20(1)

FDA requests Boxed Warnings on conventional antipsychotics
pp. 20-20(1)

SRT linked to increased risk of significant ductus arteriosus
pp. 20-20(1)

`Undesirable' lipid levels linked to HRT-related coronary events
pp. 21-21(1)

Green tea good for you?
pp. 21-21(1)

Antipsoriatic effect of methotrexate reduced by concomitant folic acid
pp. 21-21(1)

Risk of hypospadias in neonates with prenatal VA exposure
pp. 22-22(1)

Solifenacin [Vesicare] does not increase HR or BP in patients with or without cardiovascular co-morbidities
pp. 22-22(1)

Lapatinib gets EU approval for breast cancer
pp. 22-22(1)

Ropinirole gets the go ahead in the US.
pp. 22-22(1)

Tentative approval for generic irbesartan/hydrochlorothiazide issued by US FDA.
pp. 22-22(1)

Generic escitalopram approved for depression in US.
pp. 22-22(1)

Adalimumab launched in Japan.
pp. 22-22(1)

Interleukin-4-38-37-PE38KDEL gains orphan drug status
pp. 22-22(1)

Turkish approval for sale of inhaled sevoflurane.
pp. 23-23(1)

US FDA approves duloxetine for fibromyalgia.
pp. 23-23(1)